AGIO
Agios Pharmaceuticals Inc
Price:  
46.96 
USD
Volume:  
630,443.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Agios Relative Valuation

-505.1%
Upside

As of 2024-07-16, the Relative Valuation of Agios Pharmaceuticals Inc (AGIO) is (190.22) USD. This relative valuation is based on P/E multiples. With the latest stock price at 46.96 USD, the upside of Agios Pharmaceuticals Inc based on Relative Valuation is -505.1%.

The range of the Relative Valuation is (191.56) - (188.33) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 30.8x - 34.6x 31.2x
Forward P/E multiples 28.8x - 30.3x 30.0x
Fair Price (191.56) - (188.33) (190.22)
Upside -507.9% - -501.0% -505.1%
46.96 USD
Stock Price
(190.22) USD
Fair Price

Agios Relative Valuation - Historical P/E Data

Date P/E
2024-07-15 -7.56
2024-07-12 -7.39
2024-07-11 -7.15
2024-07-10 -7.00
2024-07-09 -6.87
2024-07-08 -6.63
2024-07-05 -6.87
2024-07-03 -6.77
2024-07-02 -6.77
2024-07-01 -6.98
2024-06-28 -6.94
2024-06-27 -7.02
2024-06-26 -6.98
2024-06-25 -7.19
2024-06-24 -7.28
2024-06-21 -7.28
2024-06-20 -6.83
2024-06-18 -6.85
2024-06-17 -6.86
2024-06-14 -7.10
2024-06-13 -7.53
2024-06-12 -7.72
2024-06-11 -7.65
2024-06-10 -7.60
2024-06-07 -7.66
2024-06-06 -7.70
2024-06-05 -7.86
2024-06-04 -7.62
2024-06-03 -7.06
2024-05-31 -5.85
2024-05-30 -6.04
2024-05-29 -6.12
2024-05-28 -6.25
2024-05-24 -5.07
2024-05-23 -5.26
2024-05-22 -5.38
2024-05-21 -5.45
2024-05-20 -5.34
2024-05-17 -5.53
2024-05-16 -5.63
2024-05-15 -5.66
2024-05-14 -5.50
2024-05-13 -5.40
2024-05-10 -5.31
2024-05-09 -5.30
2024-05-08 -5.23
2024-05-07 -5.28
2024-05-06 -5.35
2024-05-03 -5.56
2024-05-02 -5.57